Moreover, we also found that TRIM6 depletion inhibited the growth of B16F10 melanoma tumor in syngeneic mice and increased their response to anti-PD-L1 treatment (Fig. 2g-i, Supplementary Fig. 3a-c). This evidence concerns the gene TRIM6 and neoplasm.